1. Home
  2. CGEM vs BZH Comparison

CGEM vs BZH Comparison

Compare CGEM & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • BZH
  • Stock Information
  • Founded
  • CGEM 2016
  • BZH 1985
  • Country
  • CGEM United States
  • BZH United States
  • Employees
  • CGEM N/A
  • BZH N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • BZH Homebuilding
  • Sector
  • CGEM Health Care
  • BZH Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • BZH Nasdaq
  • Market Cap
  • CGEM 506.1M
  • BZH 577.8M
  • IPO Year
  • CGEM 2021
  • BZH 1994
  • Fundamental
  • Price
  • CGEM $7.89
  • BZH $18.59
  • Analyst Decision
  • CGEM Strong Buy
  • BZH Strong Buy
  • Analyst Count
  • CGEM 7
  • BZH 3
  • Target Price
  • CGEM $32.86
  • BZH $39.67
  • AVG Volume (30 Days)
  • CGEM 520.6K
  • BZH 418.0K
  • Earning Date
  • CGEM 05-14-2025
  • BZH 04-30-2025
  • Dividend Yield
  • CGEM N/A
  • BZH N/A
  • EPS Growth
  • CGEM N/A
  • BZH N/A
  • EPS
  • CGEM N/A
  • BZH 3.93
  • Revenue
  • CGEM N/A
  • BZH $2,412,332,000.00
  • Revenue This Year
  • CGEM N/A
  • BZH $12.48
  • Revenue Next Year
  • CGEM N/A
  • BZH $14.99
  • P/E Ratio
  • CGEM N/A
  • BZH $4.72
  • Revenue Growth
  • CGEM N/A
  • BZH 12.27
  • 52 Week Low
  • CGEM $6.85
  • BZH $17.37
  • 52 Week High
  • CGEM $30.19
  • BZH $38.22
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 47.24
  • BZH 40.46
  • Support Level
  • CGEM $6.93
  • BZH $17.63
  • Resistance Level
  • CGEM $8.10
  • BZH $18.87
  • Average True Range (ATR)
  • CGEM 0.52
  • BZH 1.24
  • MACD
  • CGEM 0.07
  • BZH -0.05
  • Stochastic Oscillator
  • CGEM 83.20
  • BZH 33.89

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

Share on Social Networks: